Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (open in new tab).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP BAXTER CORPORATION Anticipated shortage 450MG 5G 150MG New Report 2026-02-25 278883
MYLAN-PANTOPRAZOLE T MYLAN PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2026-02-24 275166
MYLAN-VERAPAMIL SR MYLAN PHARMACEUTICALS ULC Anticipated shortage 120MG New Report 2026-02-24 278878
MYLAN-RIVASTIGMINE PATCH 5 MYLAN PHARMACEUTICALS ULC Anticipated shortage 4.6MG New Report 2026-02-24 278875
MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC Anticipated shortage 20MG 500MG New Report 2026-02-24 278872
MYLAN-LANSOPRAZOLE MYLAN PHARMACEUTICALS ULC Anticipated shortage 15MG New Report 2026-02-24 278869
MYLAN-INDAPAMIDE MYLAN PHARMACEUTICALS ULC Anticipated shortage 1.25MG New Report 2026-02-24 278866
CLARUS MYLAN PHARMACEUTICALS ULC Anticipated shortage 40MG New Report 2026-02-24 278863
MYLAN-RIZATRIPTAN ODT MYLAN PHARMACEUTICALS ULC Actual shortage 10MG Updated Report 2026-02-24 276592
MYLAN-LAMOTRIGINE MYLAN PHARMACEUTICALS ULC Actual shortage 150MG Updated Report 2026-02-24 278278

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
20% PROSOL BAXTER CORPORATION To be discontinued 1.34G 1.35G 0.98G 0.32G 0.76G 0.6G 1.02G 1G 2.06G 1.08G 1.44G 2.76G 1.08G 1.02G 1.96G 0.05G 1.18G New Report 2026-02-25 278886
SANDOZ MONTELUKAST SANDOZ CANADA INCORPORATED Discontinued 4MG New Report 2026-02-23 278699
SANTYL SMITH & NEPHEW INC Discontinued 250UNIT New Report 2026-02-23 278673
!T3 PROCYTOX BAXTER CORPORATION To be discontinued 200MG New Report 2026-02-23 265253
EBIXA LUNDBECK CANADA INC To be discontinued 10MG New Report 2026-02-20 278530
Get it on Google Play Download on the App Store